• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

计算机探测刚地弓形虫主要表面抗原 1(SAG1)以增强弓形虫病疫苗的设计。

Computational probing of Toxoplasma gondii major surface antigen 1 (SAG1) for enhanced vaccine design against toxoplasmosis.

机构信息

Department of Parasitology, Faculty of Medical Sciences, Tarbiat Modares University, P. O. Box 14115-111, Tehran, Iran.

Department of Parasitology, Faculty of Medical Sciences, Tarbiat Modares University, P. O. Box 14115-111, Tehran, Iran.

出版信息

Microb Pathog. 2020 Oct;147:104386. doi: 10.1016/j.micpath.2020.104386. Epub 2020 Jul 11.

DOI:10.1016/j.micpath.2020.104386
PMID:32663606
Abstract

The SAG1 is a tachyzoite-specific protein critical for Toxoplasma gondii (T. gondii) adhesion to surface receptors of the host cells. In this study we've comprehensively excavated the sequence of SAG1 using online bioinformatics servers toward better vaccine design against toxoplasmosis. Web-based tools were used to assess the physico-chemical properties, post-translational modifications (PTMs), transmembrane domains, subcellular localization, secondary and 3D structures, as well as B-cell, Cytotoxic T cells (CTL) and major histocompatibility complex (MHC) epitopes. The 336 amino acid sequence possessed a molecular weight of 34829.02 D, aliphatic index of 80.15 and GRAVY score of 0.129. There was 47 PTM sites without any transmembrane domains. Also, the SAG1 protein was appointed to be immunogen and non-allergen. The secondary structure comprised 62.5% random coil, 26.79% extended strand and 10.71% alpha helix. Ramachandran plot of the refined model demonstrated 94.4% residues in the favored region, 4.8% in allowed region and 0.8% in outlier region. Additionally, various potential B-cell (linear and conformational), CTL and HTL epitopes were predicted for T. gondii SAG1. This in silico investigation would be a premise for appropriate immunization strategies against toxoplasmosis. More studies are anticipated to be done empirically using SAG1 immunoprotective epitopes combined with other antigenic compounds.

摘要

SAG1 是速殖子特异性蛋白,对于刚地弓形虫(Toxoplasma gondii,T. gondii)黏附宿主细胞表面受体至关重要。在本研究中,我们使用在线生物信息学服务器全面挖掘了 SAG1 的序列,以期更好地设计针对弓形虫病的疫苗。我们使用基于网络的工具来评估其理化性质、翻译后修饰(PTMs)、跨膜结构域、亚细胞定位、二级和 3D 结构以及 B 细胞、细胞毒性 T 细胞(CTL)和主要组织相容性复合物(MHC)表位。该 336 个氨基酸序列的分子量为 34829.02 D,脂肪指数为 80.15,克分子体积(GRAVY)得分为 0.129。有 47 个 PTM 位点没有任何跨膜结构域。此外,SAG1 蛋白被指定为免疫原而非过敏原。二级结构由 62.5%的无规则卷曲、26.79%的延伸链和 10.71%的α螺旋组成。精修模型的 Ramachandran 图谱显示 94.4%的残基处于优先区域,4.8%处于允许区域,0.8%处于边缘区域。此外,还预测了刚地弓形虫 SAG1 的各种潜在 B 细胞(线性和构象)、CTL 和 HTL 表位。这项计算机研究将为针对弓形虫病的适当免疫策略提供前提。预计将使用 SAG1 免疫保护表位与其他抗原性化合物结合进行更多的实验研究。

相似文献

1
Computational probing of Toxoplasma gondii major surface antigen 1 (SAG1) for enhanced vaccine design against toxoplasmosis.计算机探测刚地弓形虫主要表面抗原 1(SAG1)以增强弓形虫病疫苗的设计。
Microb Pathog. 2020 Oct;147:104386. doi: 10.1016/j.micpath.2020.104386. Epub 2020 Jul 11.
2
Toxoplasma gondii ROP38 protein: Bioinformatics analysis for vaccine design improvement against toxoplasmosis.刚地弓形虫 ROP38 蛋白:用于弓形虫病疫苗设计改进的生物信息学分析。
Microb Pathog. 2020 Dec;149:104488. doi: 10.1016/j.micpath.2020.104488. Epub 2020 Sep 9.
3
TgVax452, an epitope-based candidate vaccine targeting Toxoplasma gondii tachyzoite-specific SAG1-related sequence (SRS) proteins: immunoinformatics, structural simulations and experimental evidence-based approaches.TgVax452,一种基于表位的候选疫苗,针对刚地弓形虫速殖子特异性 SAG1 相关序列(SRS)蛋白:免疫信息学、结构模拟和基于实验证据的方法。
BMC Infect Dis. 2024 Aug 29;24(1):886. doi: 10.1186/s12879-024-09807-x.
4
Bioinformatics analysis of ROP8 protein to improve vaccine design against Toxoplasma gondii.生物信息学分析ROP8 蛋白以改进弓形虫疫苗设计。
Infect Genet Evol. 2018 Aug;62:193-204. doi: 10.1016/j.meegid.2018.04.033. Epub 2018 Apr 26.
5
Vaccination with a novel multi-epitope ROP8 DNA vaccine against acute Toxoplasma gondii infection induces strong B and T cell responses in mice.用一种新型多表位 ROP8 DNA 疫苗对急性弓形虫感染进行免疫接种可诱导小鼠产生强烈的 B 和 T 细胞应答。
Comp Immunol Microbiol Infect Dis. 2020 Apr;69:101413. doi: 10.1016/j.cimid.2020.101413. Epub 2020 Jan 8.
6
In silico analysis and expression of a novel chimeric antigen as a vaccine candidate against Toxoplasma gondii.计算机分析和表达一种新型嵌合抗原作为弓形虫疫苗候选物。
Microb Pathog. 2019 Jul;132:275-281. doi: 10.1016/j.micpath.2019.05.013. Epub 2019 May 9.
7
Multi-epitope vaccine expressed in Leishmania tarentolae confers protective immunity to Toxoplasma gondii in BALB/c mice.在顿河原生动物利什曼原虫中表达的多表位疫苗赋予 BALB/c 小鼠对弓形虫的保护性免疫。
Microb Pathog. 2021 Jun;155:104925. doi: 10.1016/j.micpath.2021.104925. Epub 2021 Apr 29.
8
Protective effect of a DNA vaccine delivered in attenuated Salmonella typhimurium against Toxoplasma gondii infection in mice.减毒鼠伤寒沙门氏菌递送的DNA疫苗对小鼠弓形虫感染的保护作用。
Vaccine. 2008 Aug 18;26(35):4541-8. doi: 10.1016/j.vaccine.2008.06.030. Epub 2008 Jun 30.
9
Toxoplasma gondii: Vaccination with a DNA vaccine encoding T- and B-cell epitopes of SAG1, GRA2, GRA7 and ROP16 elicits protection against acute toxoplasmosis in mice.刚地弓形虫:用编码SAG1、GRA2、GRA7和ROP16的T细胞和B细胞表位的DNA疫苗进行接种可引发小鼠对急性弓形虫病的保护作用。
Vaccine. 2015 Nov 27;33(48):6757-62. doi: 10.1016/j.vaccine.2015.10.077. Epub 2015 Oct 27.
10
Immunogenicity of in-silico designed multi-epitope DNA vaccine encoding SAG1, SAG3 and SAG5 of Toxoplasma gondii adjuvanted with CpG-ODN against acute toxoplasmosis in BALB/c mice.弓形虫 SAG1、SAG3 和 SAG5 免疫原性的计算机设计多表位 DNA 疫苗,佐剂为 CpG-ODN,用于 BALB/c 小鼠急性弓形虫病。
Acta Trop. 2021 Apr;216:105836. doi: 10.1016/j.actatropica.2021.105836. Epub 2021 Jan 21.

引用本文的文献

1
From pathogen to cure: exploring the antitumor potential of Toxoplasma gondii.从病原体到治愈方法:探索弓形虫的抗肿瘤潜力。
Infect Agent Cancer. 2025 Jun 18;20(1):39. doi: 10.1186/s13027-025-00673-z.
2
Comparative genomic studies on the TGF-β superfamily in blue whale.蓝鲸 TGF-β 超家族的比较基因组研究。
Mamm Genome. 2024 Jun;35(2):228-240. doi: 10.1007/s00335-024-10031-w. Epub 2024 Mar 11.
3
Immunoinformatic Analysis of gp46 Protein and Potential Targets for Vaccination against Leishmaniasis.免疫信息学分析 gp46 蛋白及其作为疫苗接种靶点防治利什曼病的潜力。
Recent Adv Inflamm Allergy Drug Discov. 2024;18(2):129-139. doi: 10.2174/0127722708283588240124095057.
4
Boosting Mouse Defense against Lethal Infection with Full-Length and Soluble SAG1 Recombinant Protein.用全长和可溶性SAG1重组蛋白增强小鼠对致死性感染的防御能力。
Vaccines (Basel). 2023 Nov 2;11(11):1678. doi: 10.3390/vaccines11111678.
5
Bioinformatics-based prediction and screening of immunogenic epitopes of rhoptry proteins 7, 21 and 22 as candidate vaccine target.基于生物信息学对棒状体蛋白7、21和22的免疫原性表位进行预测和筛选,作为候选疫苗靶点。
Heliyon. 2023 Jul 11;9(7):e18176. doi: 10.1016/j.heliyon.2023.e18176. eCollection 2023 Jul.
6
Analysis of a 29 kDa Protoscolex Protein (P29) as a Vaccine Candidate against Cystic Echinococcosis.分析 29 kDa 原头节蛋白(P29)作为抗囊型包虫病疫苗候选物。
Arch Razi Inst. 2023 Feb 28;78(1):323-335. doi: 10.22092/ARI.2022.359082.2367. eCollection 2023 Feb.
7
More Than Seventy Years of Research (1948-November 2021) on in Iran: A Narrative Review.伊朗七十多年(1948年 - 2021年11月)的[研究内容未给出]研究:叙述性综述
Iran J Parasitol. 2022 Apr-Jun;17(2):124-137. doi: 10.18502/ijpa.v17i2.9528.
8
Neospora caninum SRS2 Protein: Essential Vaccination Targets and Biochemical Features for Next-Generation Vaccine Design.犬新孢子虫SRS2蛋白:下一代疫苗设计的关键疫苗靶点及生化特性
Biomed Res Int. 2022 Apr 6;2022:7070144. doi: 10.1155/2022/7070144. eCollection 2022.
9
Tyrosine-Rich Oocyst Wall Protein: A Closer Look through an In Silico Prism.富含酪氨酸的卵囊壁蛋白:通过计算机模拟技术进行深入研究。
Biomed Res Int. 2021 Oct 14;2021:1315618. doi: 10.1155/2021/1315618. eCollection 2021.
10
Immunoinformatic Analysis of Calcium-Dependent Protein Kinase 7 (CDPK7) Showed Potential Targets for Vaccine.钙依赖性蛋白激酶7(CDPK7)的免疫信息学分析显示了疫苗的潜在靶点。
J Parasitol Res. 2021 Jul 8;2021:9974509. doi: 10.1155/2021/9974509. eCollection 2021.